Details for 2018759209

Up to date per 02.04.2026

Actions

Title / Product Name

MAVACAMTEN ZUR VERWENDUNG BEI DER BEHANDLUNG DER HYPERTROPHEN KARDIOMYOPATHIE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018759209

EP Publication Number

3661514

E-Number

1837717

Language

PCT Number

US18045180

Publication Date

10.06.2020 A

17.09.2025 B1

Registration Date

17.09.2025

AT Publication Date

15.10.2025

Application Date

03.08.2018

Registration Number

Priorities

04.08.2017

201762541591 P

10.11.2017

201762584537 P

07.03.2018

201862639922 P

15.05.2018

201862671585 P

IPC

A61K 31/513 20060101AFI20190208BHEP

Maximum Duration of Protection

03.08.2038

Owner

MyoKardia, Inc.1000 Sierra Point Parkway Brisbane, CA 94005US

Representative

No representatives present

Inventor

SEMIGRAN, Marc J.1000 Sierra Point Parkway Brisbane, CA 94005US

LEE, June H.1000 Sierra Point Parkway Brisbane, CA 94005US

LAMBING, Joseph1000 Sierra Point Parkway Brisbane, CA 94005US

GREEN, Eric1000 Sierra Point Parkway Brisbane, CA 94005US

EVANCHIK, Marc1000 Sierra Point Parkway Brisbane, CA 94005US

CARLSON, Timothy2331 Coronet Boulevard Belmont, CA 94002US

ZHANG, David140 Park Avenue San Carlos, CA 94070US

Information about Fees